Last update 19 Aug 2025

LIN-2102

Overview

Basic Info

Drug Type
Nanobody
Synonyms
LIN 2102, LIN2102, SLN12140
Target
complement factor
Action
inhibitors
Mechanism
complement factor inhibitors(Complement Factor inhibitors)
Therapeutic Areas
Immune System DiseasesUrogenital DiseasesHemic and Lymphatic Diseases+ [2]
Active Indication
Glomerulonephritis, IGAHemolysisAcute Kidney Injury+ [1]
Inactive Indication-
Originator Organization
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
Active Organization
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LIN-2102
NCT06945445
/ Not yet recruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Dose Study of SLN12140 Administered Subcutaneously or Intravenously in Healthy Adult Volunteers
100 Clinical Results associated with LIN-2102
Login to view more data
100 Translational Medicine associated with LIN-2102
Login to view more data
100 Patents (Medical) associated with LIN-2102
Login to view more data
100 Deals associated with LIN-2102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glomerulonephritis, IGAPhase 1
China
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
14 Apr 2025
HemolysisIND Approval
China
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
19 Aug 2025
Acute Kidney InjuryIND Application
China
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
-
dry age-related macular degenerationPreclinical
China
Linno Pharmaceuticals Inc.Linno Pharmaceuticals Inc.
07 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free